DCM
HPTX

Driehaus Capital Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Driehaus Capital Management’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-50,784
Closed -$1.33M – 583
2013
Q3 		$1.33M Sell
50,784
-1,083
-2% -$27.1K 0.05% 327
2013
Q2 		$1.14M Buy
+51,867
New +$1.14M 0.05% 334

Other funds holding HPTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HMPV
Highland Management Partners VII Cambridge, Massachusetts $5.57M AUM 94.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Driehaus Capital Management's HPTX Position: Q4 2013 in Review

Driehaus Capital Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q4 2013, closing a stake of 50,784 shares — an estimated $1.33M sold.

Driehaus Capital Management first reported a position in HPTX in Q2 2013 and held it in 2 quarters. The position peaked at $1.33M in Q3 2013. 61 funds tracked by Wall St. Rank hold HPTX as of Q4 2013.

  • Driehaus Capital Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • Driehaus Capital Management sold 50,784 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q4 2013, an estimated $1.33M.
  • Driehaus Capital Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 2 quarters.
  • Driehaus Capital Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.33M in Q3 2013.
  • 61 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q4 2013.

Based on Driehaus Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.